CCL17 and atherosclerosis: In spite of its limited capacity to directly activate antigen specific T cells, CCL17+DCs were found to have a pro-atherogenic role in limiting Tregs expansion and increasing plaque burden, because CCL17 deficient atherosclerotic mice displayed reduced T cell contents due to Treg expansion in the atherosclerosis plaque (25).